Health Trials

Qatar Cardiometabolic Cohort

ConditionCardiometabolic Diseases
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorWeill Cornell Medical College in Qatar

About this trial

Our objective is to create a cardiometabolic cohort that could be representative of the local population, consisting of Qataris and long-term residents, in order to identify the prevalence, risk factors, and clinical characteristics of cardiometabolic disorders, as well as the incidence of atherosclerotic cardiovascular disease events.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Qataris

Long-term residents (≥15 years of residence in Doha) who are not planning to leave Qatar voluntarily within the next 5 years.

Age ≥18 years.

English or Arabic speaker.

Disqualifiers

Type 1 diabetes or monogenic diabetes (e.g., MODY).

Pregnancy (self-reported).

Active cancer, under medical or radiation therapy or terminal, or cancer in remission < 1 year.

Chronic immune or chronic infectious diseases.

Trial population

Participants will be recruited at Hamad Medical Corporation

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

3,000 Participants
are grouped into 3 trial groups
Group A: Groupe 1: Controls (C)
Group B: Groupe 2: Cases-1 (pre-D)
Group C: Groupe 3: Cases-2 (T2D)

Trial outcomes

Primary outcomes

1

Comparison of the incidence of the of major adverse cardiovascular events between the three groups (control, pre-diabetes, and diabetes)

To compare the incidence of major adverse cardiovascular events (3-point MACE: cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke) across three groups of adults with established ASCVD or very high cardiovascular risk: non-diabetes, pre-diabetes, and type 2 diabetes.

Time frame
Baseline, Year 1, and Year 5

Secondary outcomes

1

Change in body mass index (BMI)

Change in BMI (kg/m²) from baseline (Year 0) to Year 1 and Year 5.

Time frame
Baseline, Year 1, and Year 5
2

Change in waist-to-hip ratio

Change in waist-to-hip ratio from baseline (Year 0) at Year 1 and Year 5.

Time frame
Baseline, Year 1, and Year 5
3

Change in fasting glucose

Change in fasting glucose from baseline (Year 0) at Year 1 and Year 5.

Time frame
Baseline, Year 1, and Year 5.
4

Change in glycated hemoglobin (HbA1c)

Change in HbA1c (%) from baseline (Year 0) at Year 1 and Year 5.

Time frame
Baseline, Year 1, and Year 5

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Weill Cornell Medical College in Qatar

Lead sponsor

Hamad Medical Corporation

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: